.svg){kind=small}
.svg){kind=small}
Blautia hydrogenotorophica
The gut microbiome plays a crucial role in overall health, with trillions of bacteria influencing digestion, immunity, and metabolic processes.
Among these, Blautia hydrogenotrophica is a noteworthy subspecies involved in hydrogen metabolism and short-chain fatty acid (SCFA) production. These compounds are essential for gut health, immune regulation, and metabolic function.
What is Blautia spp.?
Blautia spp. is an anaerobic, Gram-positive bacterial genus found in the human gut, where it affects metabolic regulation and immune health.
Comprising over 20 species, Blautia is studied for its probiotic potential, including its ability to improve insulin sensitivity, reduce inflammation, and support gut health through the production of short-chain fatty acids (SCFAs). SCFAs, like acetic acid, can help regulate metabolism and immune function.
Certain species, like B. producta, may also contribute to healthy lipid levels.
Blautia's influence extends to supporting health in conditions like obesity, type 2 diabetes, and inflammatory diseases, although further research is needed to fully understand its clinical applications.
What is Blautia hydrogenotrophica?
Blautia hydrogenotrophica is a member of the Blautia spp. genus, known for its role in fermenting dietary fibers into hydrogen and SCFAs, such as acetate, propionate, and butyrate. These SCFAs support gut barrier function, regulate inflammation, and are important for energy metabolism, impacting conditions like obesity and type 2 diabetes.
Role in Digestion and Metabolism
By fermenting carbohydrates, B. hydrogenotrophica contributes to hydrogen production, which aids other bacteria in the gut and supports a balanced microbiome.
SCFAs like acetate, produced by B. hydrogenotrophica, have anti-inflammatory effects and maintain gut integrity. They also influence metabolic health by improving insulin sensitivity and regulating weight.
Importance for Gut Health
Maintaining a healthy balance of B. hydrogenotrophica may help support gut health and prevent digestive disorders like IBS and IBD. High levels are associated with reduced inflammation, better digestion, and improved metabolic outcomes.
On the other hand, imbalances can lead to dysbiosis, which is linked to various chronic conditions.
Who Should Be Tested?
Testing for Blautia hydrogenotrophica can benefit individuals with digestive issues (e.g., IBS, IBD), metabolic conditions (e.g., obesity, diabetes), or those undergoing microbiome-based therapies.
Health-conscious individuals seeking preventive assessments can also use this test to monitor gut health.
Testing for Blautia hydrogenotrophica: Procedure and Interpretation
Testing for Blautia hydrogenotrophica is typically done through stool sample analysis. This test can be conducted using various methods, such as PCR, next-generation sequencing (NGS), or culture-based techniques.
A stool sample is collected and analyzed to quantify the presence of Blautia spp. and assess its relative abundance compared to other gut bacteria.
Always consult the ordering provider or laboratory company prior to sample collection, as special preparation, such as avoiding antibiotics or probiotics, may be necessary in the days leading up to sample collection.
Normal Reference Range
Normal reference ranges for Blautia hydrogenotrophica can vary based on the laboratory and the microbiome composition of the healthy population. Generally, the goal is to maintain a balanced ratio of Blautia hydrogenotrophica alongside other beneficial gut flora.
Clinical Significance of Elevated Levels
Higher levels of Blautia hydrogenotrophica are generally associated with positive health outcomes, particularly in relation to gut health and metabolic regulation.
Elevated Blautia hydrogenotrophica may suggest active fermentation, optimal SCFA production, and improved gut health. High levels may be linked to reduced inflammation, enhanced digestion, and better metabolic function, including weight regulation and insulin sensitivity.
While the research generally supports benefits with Blautia hydrogenotrophica prevalence, maintaining a balance of commensal bacteria in the microbiome is generally recommended.
Clinical Significance of Decreased Levels
Low levels are associated with compromised gut health, inflammation, and a higher risk of metabolic and immune-related conditions.
A decrease in Blautia hydrogenotrophica may be associated with reduced SCFA production, gut barrier dysfunction, and chronic low-grade inflammation. Gut barrier dysfunction has been observed in patients with obesity, type 2 diabetes, cardiovascular diseases, and autoimmune disorders.
Order Microbiome Testing
Click here to compare testing options and order testing for microbiome balance.
Benítez-Páez, A., Gómez del Pugar, E. M., López-Almela, I., Moya-Pérez, Á., Codoñer-Franch, P., & Sanz, Y. (2020). Depletion of Blautia Species in the Microbiota of Obese Children Relates to Intestinal Inflammation and Metabolic Phenotype Worsening. MSystems, 5(2). https://doi.org/10.1128/msystems.00857-19
den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D. J., & Bakker, B. M. (2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of lipid research, 54(9), 2325–2340. https://doi.org/10.1194/jlr.R036012
Du, Y., He, C., An, Y., Huang, Y., Zhang, H., Fu, W., Wang, M., Shan, Z., Xie, J., Yang, Y., & Zhao, B. (2024). The Role of Short Chain Fatty Acids in Inflammation and Body Health. International journal of molecular sciences, 25(13), 7379. https://doi.org/10.3390/ijms25137379
Germano, R., Carolina, A., Fernandes, G., Francieli Barreiro Ribeiro, Solar, I., Marina Rodrigues Barbosa, Bianca, Geloneze, B., & Roberta, S. (2022). Associations of Blautia Genus With Early-Life Events and Later Phenotype in the NutriHS. 12. https://doi.org/10.3389/fcimb.2022.838750
Holmberg, S. M., Feeney, R. H., Prasoodanan P. K., V., Puértolas-Balint, F., Singh, D. K., Wongkuna, S., Zandbergen, L., Hauner, H., Brandl, B., Nieminen, A. I., Skurk, T., & Schroeder, B. O. (2024). The gut commensal Blautia maintains colonic mucus function under low-fiber consumption through secretion of short-chain fatty acids. Nature Communications, 15(1), 3502. https://doi.org/10.1038/s41467-024-47594-w
Liu, X., Mao, B., Gu, J., Wu, J., Cui, S., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2021). Blautia-a new functional genus with potential probiotic properties?. Gut microbes, 13(1), 1–21. https://doi.org/10.1080/19490976.2021.1875796
Liu, X. F., Shao, J. H., Liao, Y. T., Wang, L. N., Jia, Y., Dong, P. J., Liu, Z. Z., He, D. D., Li, C., & Zhang, X. (2023). Regulation of short-chain fatty acids in the immune system. Frontiers in immunology, 14, 1186892. https://doi.org/10.3389/fimmu.2023.1186892
Smith, N. W., Shorten, P. R., Altermann, E. H., Roy, N. C., & McNabb, W. C. (2019). Hydrogen cross-feeders of the human gastrointestinal tract. Gut microbes, 10(3), 270–288. https://doi.org/10.1080/19490976.2018.1546522
Wang, T., Leibrock, N., Plugge, C. M., Smidt, H., & Zoetendal, E. G. (2023). In vitro interactions between Blautia hydrogenotrophica, Desulfovibrio piger and Methanobrevibacter smithii under hydrogenotrophic conditions. Gut microbes, 15(2), 2261784. https://doi.org/10.1080/19490976.2023.2261784
Wilkins, L. J., Monga, M., & Miller, A. W. (2019). Defining Dysbiosis for a Cluster of Chronic Diseases. Scientific reports, 9(1), 12918. https://doi.org/10.1038/s41598-019-49452-y
Xu, W., Yu, J., Yang, Y., Li, Z., Zhang, Y., Zhang, F., Wang, Q., Xie, Y., Zhao, B., & Wu, C. (2023). Strain-level screening of human gut microbes identifies Blautia producta as a new anti-hyperlipidemic probiotic. Gut microbes, 15(1), 2228045. https://doi.org/10.1080/19490976.2023.2228045
Test for
Blautia hydrogenotorophica
